Ctt Pharmaceutical
(OTC) CTTH
Ctt Pharmaceutical Financials at a Glance
Market Cap
$4.48M
Revenue (TTM)
$0.00
Net Income (TTM)
$132.72K
EPS (TTM)
$-0.00
P/E Ratio
-23.86
Dividend
$0.00
Beta (Volatility)
-0.56 (Low)
Dividend
$0.00
Beta (Volatility)
-0.56 (Low)
Price
$0.08
Volume
27,000
Open
$0.08
Price
$0.08
Volume
27,000
Open
$0.08
Previous Close
$0.08
Daily Range
$0.08 - $0.08
52-Week Range
$0.02 - $0.10
Dividend
$0.00
Beta (Volatility)
-0.56 (Low)
Price
$0.08
Volume
27,000
Open
$0.08
Previous Close
$0.08
Daily Range
$0.08 - $0.08
52-Week Range
$0.02 - $0.10
CTTH News
CTTH: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ctt Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareCEO
Ryan Khouri
Website
www.cttpharmaceuticals.comHeadquarters
Ottawa, ON K2P 2B4, CA
CTTH Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-682%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-4.19%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.48M
Shares Outstanding
58.71M
Volume
27.00K
Short Interest
0.00%
Avg. Volume
55.53K
Financials (TTM)
Gross Profit
$6.40K
Operating Income
$250.00K
EBITDA
$243.83K
Operating Cash Flow
$33.87K
Capital Expenditure
$0.00
Free Cash Flow
$33.87K
Cash & ST Invst.
$114.00
Total Debt
$16.93K
Ctt Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.60K
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.48M
N/A
Market Cap/Employee
$2.24M
N/A
Employees
2
N/A
Net Income
$7.27K
+93.1%
EBITDA
$5.67K
+94.6%
Quarterly Fundamentals
Net Cash
$15.04K
+238.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$17.40K
+60.0%
Return on Assets
-1.30%
N/A
Return on Invested Capital
-1.60%
N/A
Free Cash Flow
$16.40K
-43.0%
Operating Cash Flow
$16.39K
-42.9%